Ethypharm S.A. – Strategic SWOT Analysis Review – new company profile report – Transworld News

The company’s product portfolio comprises buprenorphine, donepezil, esomeprazole, fenofibrate, fentanyl, ketoprofen-omeprazole, mirtazapine, morphine sulfate, ondansetron, omeprazole, oxycodone, secnidazole, tramadol and venlafaxine. Additionally …